Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Divestments (2010 - 2012)

Lemaitre Vascular (LMAT) reported Divestments of $250000.0 for Q4 2012, up 8233.33% year-over-year from $3000.0 in Q1 2012, and up 117.39% on a QoQ basis from $115000.0 in Q3 2012.

Lemaitre Vascular (LMAT) has 3 years of Divestments data on file, last reported at $250000.0 in Q4 2012.

  • Quarterly Divestments rose 8233.33% year-over-year to $250000.0 in Q4 2012, while the trailing twelve-month figure through Dec 2018 was $250000.0 (changed N/A YoY) and the FY2018 annual result came in at $7.4 million, changed N/A from the prior year.
  • Divestments climbed to $250000.0 in Q4 2012 per LMAT's latest filing, from $115000.0 in the prior quarter.
  • Across five years, Divestments topped out at $1.3 million in Q3 2011 and bottomed at $2000.0 in Q3 2010.
  • The 3-year median for Divestments is $54500.0 (2010), against an average of $192300.0.
  • The widest annual swing landed in 2011, when Divestments jumped 65050.0%; it then plunged 91.17% in 2012.
  • Tracing LMAT's Divestments over 3 years: stood at $7000.0 in 2010, then slumped by 57.14% to $3000.0 in 2011, then jumped by 8233.33% to $250000.0 in 2012.
  • Per Business Quant, the three latest LMAT Divestments figures stand at $250000.0 (Q4 2012), $115000.0 (Q3 2012), and $131000.0 (Q2 2012).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn -
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -
10 Lemaitre Vascular 2.28 Bn 1.91 Bn 48.40 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2012 250,000.00
Sep 30, 2012 115,000.00
Jun 30, 2012 131,000.00
Mar 31, 2012 4,000.00
Dec 31, 2011 3,000.00
Sep 30, 2011 1.30 Mn
Jun 30, 2011 102,000.00
Mar 31, 2011 6,000.00
Dec 31, 2010 7,000.00
Sep 30, 2010 2,000.00